Delivery Order SPE2DB20D3101-SPE2DB25FRDD9

Award Date 2/27/25
Potential Completion Date 2/28/25
Potential Value $6.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4560956671 LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA). The contract, valued at $2,100.58, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of May 17, 2023. The award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,777.86, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 4, 2025. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The $2,268.31 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 23, 2024, with a completion date of December 24, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Medical Supply Chain, a division of the Defense Logistics Agency (DLA). The $17,441.85 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 23, 2024. The contract is not set aside and has an ultimate completion date of August 26, 2024. This award is likely part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of LIDOCAINE 5% PATCH 30S medical supplies. The contract, valued at $1,113.99, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 18, 2024 with a ceiling value of $4,506.10. The contract is a Delivery Order with a Firm Fixed Price type and has a completion date of June 20, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award is a delivery order valued at $1,463.59, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4567118692 LIDOCAINE 5% PATCH 30S, a medical product used for pain management. The contract has an ultimate completion date of February 3, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4560683499 LIDOCAINE 5% PATCH 30S. The contract has a firm fixed price of $14,279.13 and a completion date of April 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,113.26 firm fixed-price delivery order is for the supply of 4565019958 LIDOCAINE 5% PATCH 30S. The contract has an ultimate completion date of June 28, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award is for the delivery of 4565057967 LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $3,103.20. The contract has an ultimate completion date of July 3, 2024. This is a firm fixed price delivery order contract, and there is no set-aside designation. Amerisourcebergen holds a larger...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRDD9
    Delivery Order

This federal contract award is for the delivery of 4567411051 LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The firm fixed-price delivery order, valued at $6,677.81, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 27, 2025, with a completion date of February 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/1/25, 3:25 AM